Vyaire Medical’s Virtual Auction Post-Bankruptcy: MedTech Industry Shifts

Vyaire Medical has taken a decisive step following their filing for Chapter 11 bankruptcy protection in June by holding a virtual auction of assets. This significant move comes in the wake of various financial strains and market challenges faced by the company.

The news comes at a pivotal time for Vyaire Medical, which reported a remarkable spike in ventilation revenue during the height of the COVID-19 pandemic—jumping from $215 million in 2019 to an impressive $620 million in 2020.

The Palm Springs facility, a cornerstone of Vyaire’s operations, was operating at just 20% capacity when the bankruptcy filing occurred. Compounding these operational challenges were soaring costs, including an eight-fold increase in the price of medical-grade resin.

At the onset of the Chapter 11 process, Vyaire signaled their openness to separate bids for both their ventilation and respiratory diagnostics businesses, as well as offers for the entire portfolio of assets. This strategic move aims to maximize the value captured for creditors and potentially pave the way for a streamlined, revitalized business model.

The virtual auction of Vyaire Medical’s assets marks a significant juncture not only for the company but also for the medtech industry at large. As Vyaire navigates through financial restructuring, the outcomes will be closely watched by industry experts and competitors alike.